In this translational study, we identified and validated KRAS mutations (but not GNAS mutations) as a poor prognostic factor in patients treated with peritonectomy and HIPEC for peritoneal pseudomyxoma.
from Cancer via ola Kala on Inoreader http://ift.tt/2b2pPNE
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου